IFN-γ response to these RD1 selected peptides can be detected in individuals with ongoing M. tuberculosis replication (such as during active TB disease and/or recent TB infection) and has been shown to significantly decrease in Human Immunodeficiency Virus (HIV) uninfected [17,18] or infected individuals [30] during TB prophylaxis and therapy. This evidence concerns the gene PDE6B and tuberculosis.